Biotech China 2014

Drug Design: Bayer AG

Total Score People Score Events Score
26 21 24
Date Event Presentation Speakers
August 5, 2009 Targets in Context - Linking Targets to Diseases Agenda Innovation by Novel and Established Drug Targets Khusru Asadullah
July 1, 2009 Advances in Oral Dose Manufacturing Applying Analytical Techniques for Physical and Chemical Characterisation Gabriele Winter
June 9, 2009 Cell and Tissue-Based Assays for HTS Developing High Quality Assays for Screening 2.5 Million Compounds Elisabeth Pook
February 9, 2009 Immunogenicity for Biologics 2009 Practical experience of immunogenicity in early clinical trials Johannes Nagelschmitz
February 8, 2009 CHEMISTRY IN CANCER RESEARCH: A Vital Partnership in Cancer Drug Discovery and Development Session 10: Chemistry in Support of Cancer Drug Discovery and Development II Johannes Platzek
January 28, 2009 Electronic Laboratory Notebooks LABORATORY INFORMATION MANAGEMENT SYSTEMS : Case Study Bhanu Sharma
January 27, 2009 6th Annual Clinical Trial Performance Metrics Real life examples of how metrics have been used to develop Process Improvement Initiatives Louise Anderson
January 26, 2009 Circulating HER-2/neu, A Biomarker for HER-2 Positive Breast Cancer, from Discovery to Patient Management Walter P. Carney
January 26, 2009 Biomarker Assay Development Circulating HER-2/neu, A Biomarker for HER-2 Positive Breast Cancer, from Discovery to Patient Management Walter P. Carney
January 5, 2009 High Content Analysis Effective Support of Oncology Driven Drug Research by Functional High-Content Analysis Stefan Prechtl
December 2, 2008 2nd Annual Lead Discovery Summit 2008:-Compound Library Design, Synthesis & Acquisition High content analysis from a screening and chemistry perspective: How effectively can data be used to direct compound design and future screening campaigns? Philip Denner
December 2, 2008 The 8th World Drug Discovery & Development Summit 2008 R&D RISK MANAGEMENT - THE INTEGRATED APPROACH Bernd Seilheimer
November 26, 2008 4th Annual Audits and Inspections for Clinical Trials and Pharmacovigilance Real life experience of an FDA Sponsor Inspection – how to cope with the increasing requirements of the inspection process Peter Odenthal,
November 17, 2008 BIO-Europe 2008 Rethinking R&D: Can Big Pharma Address the Productivity Gap through Earlier-Stage Collaborations? Michael A. Yeomans
May 4, 2008 Impact China IV: Pharmaceutical R&D Global Summit Conducting Clinical Trials in China Min Irwin
February 19, 2008 ADMET Europe ADME Prediction Mario Lobell
In silico ADMET Traffic Lights and PhysChem Scores and Their Application to Kinase Inhibitors Mario Lobell
December 5, 2007 REACH REACH - What are the obligations of the pharmaceutical industry? Dr Andrea Paetz
December 1, 2007 47TH American Socieity of Cell Biology Establishing and Characterizing Embryonic Stem Cell Lines Min Irwin
November 27, 2007 Fifth Annual Strategic Resource Management: The Key to Increasing R&D Productivity Nov (27-28) Developing Harmonized Resource and Costs Management Processes and Tools (11:00-11:45) Robin Myers, Jaya Pal
INTERACTIVE PANEL DISCUSSION: Creating a Process to Successfully Transfer Internal and External Resources among Projects (11:45-12:30) Robin Myers
October 24, 2007 Virtual Discovery Europe Computer-Aided Drug Design And Screening In silico ADMET Traffic Lights and PhysChem Scores and Their Application to Kinase Inhibitors Mario Lobell
October 17, 2007 Inaugral Nuclear Harmone Receptors Modulators: Targets for Drug Discovery Oct (17-18) INNOVATIVE TECHNOLOGIES FOR NHR MODULATORS (13:55-17:10) Siegmund Wolf
Featured Presentation - Tissue-Specific Nuclear Receptor Comodulators as Predictors of Selective Hormone Action Revealed Through the Example of the Androgen Receptor (16:10-16:40) Siegmund Wolf
October 15, 2007 2nd Annual Innovations in Clinical Trials: Implementations of Biomarkers (Oct15-16) BIOIMAGING FOR MONITORING RESPONSE TO THERAPY, DOSE SELECTION, ASSESSING MOLECULAR ACTIVITY AND RECEPTOR OCCUPANCY (08:00-13:30) Walter P. Carney
Circulating Oncoproteins as Cancer Biomarkers for Targeted Therapies (11:00-11:30) Walter P. Carney
October 10, 2007 Drug Repositioning Summit: Finding New routes to success (Oct 10-11) REPROFILING DRUGS (08:30-13:30) Hans-Joachim Zeiler
REPROFILING DRUGS: CIPRO - The Creation of a New Blockbuster (09:45-10:15) Hans-Joachim Zeiler
September 24, 2007 High-Content Analysis Europe: High content Cellular Assays for compound screening and Pahtway Analysis (Sep 24-26) HCA for Mechanism-of-Action Studies: Development of Automated Image Analysis Routines for Functional HCA (16:30-17:00) Philip Denner
HCA for Mechanism-of-Action Studies (16:00-18:00) Philip Denner
Biotech China 2014
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.